FDA Approves Roche’s Susvimo for Diabetic Retinopathy
Genentech/Roche’s sustained release anti-VEGF eye implant provides a treatment option with reduced frequency for diabetic retinopathy. Sustained release anti-VEGF is…
Advances in AMD and DME Take Center Stage at APAO 2025
From imaging biomarkers to next-gen therapeutics, experts explored translational tools shaping the future of AMD and diabetic eye disease. At…
latest posts
